{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T16:14:11Z","timestamp":1726503251076},"reference-count":0,"publisher":"MJH Life Sciences","issue":"3510","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,12]]},"DOI":"10.46883\/onc.2021.3510.0665","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T17:49:29Z","timestamp":1634924969000},"page":"665-667","source":"Crossref","is-referenced-by-count":0,"title":["Opsoclonus-Myoclonus\u2013Associated Neuroblastoma With Bone Marrow Metastases: What Would Be the Best Treatment Option?"],"prefix":"10.46883","member":"25947","published-online":{"date-parts":[[2021,10,22]]},"container-title":["ONCOLOGY"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T17:49:30Z","timestamp":1634924970000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cancernetwork.com\/view\/journal-opsoclonus-myoclonus-associated-neuroblastoma-with-bone-marrow-metastases-what-would-be-the-best-treatment-option-"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,12]]},"references-count":0,"issue-title":["October 2021"],"journal-issue":{"issue":"3510","published-online":{"date-parts":[[2021,10,18]]},"published-print":{"date-parts":[[2021,10,12]]}},"URL":"https:\/\/doi.org\/10.46883\/onc.2021.3510.0665","relation":{},"ISSN":["0890-9091"],"issn-type":[{"type":"print","value":"0890-9091"}],"subject":[],"published":{"date-parts":[[2021,10,12]]}}}